 Home > Medical News > Latest Medical News > Roche and FDA start negotiations on Alzheimer's disease drug candidate Gantenerumab

Roche and FDA start negotiations on Alzheimer's disease drug candidate Gantenerumab

 Last Update: 2021-07-31
 Source: Internet
 Author: User

Tags

melatonin drug test

therapeutic drug monitoring

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationTom Lee

Roche is currently negotiating with the U.

According to a study published in Nature Medicine in June this year, Gantenerumab improved the levels of many biomarkers in patients with hereditary Alzheimer's disease

The DIAN-TU-001 (NCT01760005) trial compared Gantenerumab manufactured by Roche and its US subsidiary Genentech and Solanezumab manufactured by Eli Lilly against patients with rare, inherited, and early-onset Alzheimer’s The curative effect of patients

Researchers said that the patients participating in the trial are in multiple stages of asymptomatic and symptomatic diseases

Schwan revealed that Roche plans to complete Phase 3 trials of the drug in the second half of 2022

Gantenerumab is a monoclonal antibody targeting β amyloid peptide

The advocacy of the Alzheimer's disease amyloid hypothesis in the pharmaceutical industry seems to have signs of recovery, thanks to BioGen's controversial Aduhelm

Reference source: Roche engaged in talks with FDA for Alzheimer's drug candidate

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.